#Coronavirus Disease Research #References (by AMEDEO, April 25 '26)

 

Ann Intern Med

1. FRITZ JM, Skolasky RL, Brennan G, Minick K, et al
   Effectiveness of Nonpharmacologic Treatments for Chronic Low Back Pain : A Sequential, Multiple-Assignment, Randomized Trial.
   Ann Intern Med. 2026 Apr 21. doi: 10.7326/ANNALS-25-04645.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. BAKER JV, Siegel L, Losso M, Vasudeva S, et al
   Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.
   Clin Infect Dis. 2026 Apr 22:ciag272. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

3. ZHAO CY, Wang FS, Jiao YM
   SARS-CoV-2 infection disrupts the immune control status in a male HIV-1 elite controller.
   Int J Infect Dis. 2026 Apr 20:108713. doi: 10.1016/j.ijid.2026.108713.
   PubMed         Abstract available
   
   

   
   J Infect

4. BEHARIER O, Guedalia J, Sehtman-Shachar DR, Kerem L, et al
   Maternal SARS-CoV-2 Infection and Early Child Growth and Development: A Nationwide Cohort Study.
   J Infect. 2026 Apr 17:106749. doi: 10.1016/j.jinf.2026.106749.
   PubMed         Abstract available
   
   

   
   J Med Virol

5. HO SY, Liu YC, Ho SY, Chen SH, et al
   Emergence of Echovirus 11 in Severe and Neonatal Enterovirus Infections: A 9-Year Retrospective Study in Taiwan Before and After the COVID-19 Pandemic.
   J Med Virol. 2026;98:e70929.
   PubMed         Abstract available
   
   
6. AVILA JP, Park P, Singh Y, Amaral PP, et al
   Multiorgan Molecular Landscape of Severe COVID-19 Revealed by Consensus Gene Signatures and RAB8B Targeting.
   J Med Virol. 2026;98:e70932.
   PubMed         Abstract available
   
   
7. KESKIN S, Pavel STI, Sak R, Bahadori F, et al
   Modified mRNA Encoding the Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein Confers Robust Protection Against Lethal Challenge in Mice.
   J Med Virol. 2026;98:e70940.
   PubMed         Abstract available
   
   

   
   J Virol

8. SALISCH F, Muller-Ruttloff C
   Behind the membranous curtain-lipid dynamics and functions in coronaviral replication.
   J Virol. 2026 Apr 21:e0175325. doi: 10.1128/jvi.01753.
   PubMed         Abstract available
   
   
9. YANG M, Zhao Y, Guo W, Wang L, et al
   Development of a vaccine based on mRNA assembly of PEDV virus-like particle.
   J Virol. 2026 Apr 21:e0206025. doi: 10.1128/jvi.02060.
   PubMed         Abstract available
   
   
10. ZHANG K, Wang S, Kang X, Li F, et al
    Swine GBP1 restricts PDCoV replication via disrupting the replication and transcription complex formation.
    J Virol. 2026 Apr 21:e0020726. doi: 10.1128/jvi.00207.
    PubMed         Abstract available
    
    
11. ZHAO J, Tian J, Zhang L, Li Y, et al
    Coronavirus infectious bronchitis virus spike protein inhibits FUNDC1-mediated mitophagy to prevent nucleocapsid protein degradation.
    J Virol. 2026 Apr 20:e0180025. doi: 10.1128/jvi.01800.
    PubMed         Abstract available
    
    
12. MU S, Bai Y, Qiu R, Zhang F, et al
    Porcine hemagglutinating encephalomyelitis virus nucleocapsid protein targets RIG-I and IRF3 to evade IFN immunity.
    J Virol. 2026 Mar 30:e0211225. doi: 10.1128/jvi.02112.
    PubMed         Abstract available
    
    
13. ZHANG X, Li Y, Yuan J, Li Q, et al
    Metformin hydrochloride regulates glycolysis and inhibits PEDV replication by inhibition of PI3K-AKT signaling pathway.
    J Virol. 2026;100:e0014726.
    PubMed         Abstract available
    
    

    
    JAMA

14. LEFF B, Siu A, DeCherrie LV, Levine DM, et al
    Hospital at Home and Transforming US Health Care Delivery.
    JAMA. 2026 Apr 23. doi: 10.1001/jama.2026.4791.
    PubMed        
    
    
15. KUKOYI OM, Wang VS, Yao K, Cipriano CB, et al
    US State Actions Related to COVID-19 Vaccination Infrastructure and Access Amid Federal Shifts.
    JAMA. 2026 Apr 20:e265148. doi: 10.1001/jama.2026.5148.
    PubMed        
    
    

    
    Lancet Infect Dis

16. ZHANG L, Hoffmann M, Pohlmann S
    Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution?
    Lancet Infect Dis. 2026 Apr 17:S1473-3099(26)00192.
    PubMed        
    
    

    
    N Engl J Med

17. BUTLER CC, Pinto AD, Harris V, Holmes J, et al
    Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
    N Engl J Med. 2026;394:1583-1594.
    PubMed         Abstract available
    
    

    
    Nature

18. GALLO G, Di Nardo A, Lugano D, Roberts AJ, et al
    Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells.
    Nature. 2026 Apr 22. doi: 10.1038/s41586-026-10394.
    PubMed         Abstract available
    
    
19. YAN H
    A bat coronavirus can enter human cells through a previously unknown gateway.
    Nature. 2026 Apr 22. doi: 10.1038/d41586-026-00908.
    PubMed